DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

People / Michael Krel

Michael Krel

PartnerPartner, Sofinnova Partners - Industrial Biotech StrategySofinnova Partners

Roles

2 current, 0 past

Sofinnova Partners Partner
? to present · “said Michael Krel, Partner at Sofinnova Partners. The”
Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Sofinnova Partners Partner, Sofinnova Partners - Industrial Biotech Strategy
? to present · “team page: Michael Krel / Partner, Sofinnova Partners - Industrial Biotech Strategy”
Fact Venture organization websites (about, team, portfolio, thesis, news pages)

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
P2 Science	Funding round · $23.0M	Sofinnova Partners	confirmed	May 26, 2026	Fact prnewswire.com

Board seats and vehicles

0 boards, 0 vehicles

None on record.

Timeline

No dated event.